decisionhealth Newsletters, Part B News - 2016 Issue 10 (October)
Navigate screening vs. diagnostic tests to successfully report prostate screens
Subscribe or sign in to view the full article.
Article Overview
This premium coding article focuses on Medicare prostate cancer screening and PSA-related reporting. It helps readers understand the difference between preventive screening and diagnostic testing, how diagnosis coding supports coverage, and why certain claims are denied when the test type or supporting diagnosis is mismatched. The guidance is aimed at coding professionals, billers, and clinicians who submit or review preventive urology claims under Medicare rules.
Why This Topic Matters
Prostate screening claims are a frequent source of denials, so accurate identification of test type and supporting diagnosis coding is essential for compliant reimbursement and fewer rejected claims.
Article Sections
-
Coding
Overview of the PSA screening topic and the general coding problem addressed by the article.
-
Differentiate screening vs. diagnostic
Discussion of how the article separates preventive screening from diagnostic testing, including the broader Medicare coverage context and claim-support considerations.
What You Will Learn
- How the article frames preventive prostate screening versus diagnostic PSA testing
- What kinds of Medicare coverage and denial issues are associated with prostate screening claims
- Which general types of diagnosis support are discussed for prostate-related testing
- How frequency and medical necessity considerations are presented at a high level
Who Should Read This
- Medical coders
- Billing staff
- Compliance staff
- Primary care practices
- Urology practices
- Clinicians who order preventive screenings
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com